Twana Mohsin Salih
Qualification: PhD Medicinal Chemistry, MSc. Pharmaceutical Chemistry, BSc. Pharmacy
Position: Assistant Professor
Profession : Medicinal Chemistry and Drug Discovery
Address: Second Floor, First Building, College of Pharmacy, University of Sulaimani, Town Campus
Email Address: twana.salih@univsul.edu.iq
Mobile: +964 (0) 770 146 2171
Outline Biography
My initial academic pursuit led to the attainment of a bachelor’s degree in pharmacy in 2003. Subsequently, I continued my academic journey at College of Pharmacy-Hawler Medical University, focusing on Pharmaceutical Chemistry under the supervision of Professor Kawkab Saour, culminating in the completion of a Master of Science degree. The research during this period centered on the synthesis of novel adenosine 5’ peptidyl derivatives with anticipated biological activity. Following this, I transitioned to the Centre of Biomolecular Sciences (CBS) at the School of Pharmacy-University of Nottingham, United Kingdom. There, I collaborated with Professor Charlie Laughton and Professor Weng Chan, delving into the exploration of protein-protein interaction inhibitors in telomeres for cancer treatment. This experience ignited a profound interest in cancer chemotherapy and computational chemistry, which subsequently became focal points of my academic pursuits starting from 2011. Returning to my home university in 2016, I assumed the role of Lecturer in the College of Pharmacy. In 2017, I was entrusted with the leadership of the Pharmacognosy and Pharmaceutical Chemistry department. Recognising my contributions, I was promoted to the position of Assistant Professor in Medicinal Chemistry in 2022, concurrently assuming the responsibilities of a Dean within the College of Pharmacy at the University of Sulaimani.
Research Interests
My research interest includes the following fields;
1. Inhibiting protein-protein interaction as an approach of new therapeutics
2. Computational chemistry and molecular modelling in drug discovery
3. Confronting bacterial resistance and new chemical entities for antibacterial resistance pathogens